Assisting IUD and DMPA Users with Overcoming their Sexual and Mood Problems

Assisting IUD and DMPA Users with Overcoming their Sexual and Mood Problems

Background: Contraceptive side effects have been recognized as the most important reasons accounting for discontinuation of the methods. Objectives: The present study attempts to identify the probable side effects that negatively affect sexual satisfaction and depression in Intra Uterine Device (...

Full description

Bibliographic Details
Main Author:	Farnaz Farnam
Format:	Article
Language:	English
Published:	Zanjan University of Medical Sciences and Health Services 2020-04-01
Series:	Preventive Care in Nursing and Midwifery Journal
Subjects:	copper intra uterine device depo-medroxyprogesterone acetate sexual satisfaction depression associated factors
Online Access:	http://zums.ac.ir/nmcjournal/article-1-619-en.pdf

Similar Items

The effect of the copper intrauterine device (Cu-IUD) and the injectable depo-medroxyprogesterone acetate (DMPA) use on women’s sexual satisfaction and depression
by: Samaneh Hagh-Mohammadi Pasanad, et al.
Published: (2020-01-01)

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive
by: Robyn Schickler, et al.
Published: (2021-01-01)

Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis
by: Ashraf Nabhan, et al.
Published: (2021-10-01)

The comparative study of side effect DMPA with OCP (LD) in reproductive women referring to health center in Kalaleh
by: Mirmohammadali, et al.
Published: (2002-11-01)

The comparative study of side effect DMPA with OCP (LD) in reproductive women referring to health center in Kalaleh
by: M Mirmohammadali, et al.
Published: (2002-05-01)

STUDI OPERASIONAL PENINGKATAN PEMAKAIAN KONTRASEPSI IUD DI PROVINSI BALI
by: Desak Putu Eka Nilakusmawati, et al.
Published: (2012-12-01)

Hormonal Contraception and Bone Health in Adolescents
by: Laura K. Bachrach
Published: (2020-08-01)

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial
by: Mags Beksinska, et al.
Published: (2021-04-01)

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa
by: Lisa M. Noguchi, et al.
Published: (2021-07-01)

Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem.
by: Firoozeh Veisi, et al.
Published: (2013-09-01)

Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD
by: Seyed Javad Purafzali Firuzabadi, et al.
Published: (2012-01-01)

High-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery
by: Kathleen L. Vincent, et al.
Published: (2021-06-01)

Avaliação da densidade mineral ossea em mulheres na pós-menopausa ex-usuarias do contraceptivo medroxiprogesterona de deposito
by: Sanches, Luciana
Published: (2008)

Medroxyprogesterone to treat corneal thinning postcurvularia keratitis
by: Lubna Khan, et al.
Published: (2019-01-01)

Faktor yang Berhubungan dengan Penggunaan Intra Uterine Device (IUD) di Pusat Pelayanan Keluarga Sejahtera (Pusyan Gatra) Tahun 2016
by: Sarah Christiawan, et al.
Published: (2018-10-01)

Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01)

The impact of the steroid hormones medroxyprogesterone acetate, cortisol and progesterone on protective immunity to tuberculosis
by: Kleynhans, Leanie
Published: (2012)

Pelvic Mass Due to Transmigrated IUD
by: Nadereh Behtash, et al.
Published: (2010-03-01)

Pelvic Mass Due to Transmigrated IUD
by: Nadereh Behtash, et al.
Published: (2010-04-01)

Laparoscopic retrieval of transmigrated IUDS (report of 3 cases).
by: Virkud A, et al.
Published: (1989-04-01)

Pengaruh Penyuluhan Media Video terhadap Peningkatkan Pengetahuan dan Sikap tentang Kontrasepsi Intra Uterine Devices (IUD) pada Pasangan Usia Subur di Kecamatan Gunung Pati Semarang
by: Rizky Amelia, et al.
Published: (2020-04-01)

Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up
by: Gisele Almeida Batista, et al.
Published: (2016-09-01)

The effect of medroxyprogesterone acetate on pregnancy rates in reindeer calves (Rangifer tarandus)
by: Erik Ropstad, et al.
Published: (1993-12-01)

Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity
by: Xiangxu Jia, et al.
Published: (2021-09-01)

Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
by: P. Silva, et al.
Published: (2018-04-01)

Bilateral ovarian actinomycosis masquerading as ovarian malignancy; without any history of intra-uterine contraceptive device
by: Ghante Nagaraj Srinivas, et al.
Published: (2013-01-01)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
by: Liang Z, et al.
Published: (2020-12-01)

Effect of medroxyprogesterone acetate on thyrotropin secretion in adult and old female rats
by: R.M. Moreira, et al.
Published: (2000-09-01)

Quantification of collagen fibers in canine uteri treated with medroxyprogesterone acetate
by: Paulo Salinas, et al.

Brain metastases from breast cancer may respond to endocrine therapy: report of two cases
by: Wang Q, et al.
Published: (2019-02-01)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
by: Yunxia Cui, et al.
Published: (2021-04-01)

Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), a copper intrauterine device (IUDs) or a levonorgestrel (LNG) implant for contraception
by: Maricianah Onono, et al.
Published: (2020-01-01)

Effectiveness of Counseling on the Willingness to Use Intra-Uterine Device Contraceptive after Placenta Detachment among the Health Insurance Participants in Panembahan Hospital, Bantul
by: Ristiana Eka Ariningtyas, et al.
Published: (2016-01-01)

Determinação espectrofotometrica de acetato de medroxiprogesterona em medicamento pela reação com Mo (VI) em 'H IND. 2' S'O IND. 4'
by: Pinheiro, Tania Aparecida Lopes
Published: (2006)

Study of Sexual Dysfunction among Females with Combined Oral Contraception [COC] versus Intrauterine Hormonal Device
by: Alaa Talaat, et al.
Published: (2020-07-01)

Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review
by: Nerea M. Casado-Espada, et al.
Published: (2019-06-01)

Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives
by: Deese J, et al.
Published: (2018-11-01)

Lippes Loop Inserted 45 Years Back: The Dilemma to Remove It or Leave It in situ. A Case Report with Review of Literature
by: Maruti Sinha, et al.
Published: (2015-04-01)

Apparent rarity of asymptomatic herpes cervicitis in a woman with intra-uterine contraceptive device
by: Adeola Fowotade, et al.
Published: (2013-12-01)

Investigation of knowledge level about intrauterine device
by: Hediye Dagdeviren, et al.
Published: (2013-06-01)